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Spread of Pacific Northwest Vibrio parahaemolyticus Strain
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To the Editor
Globally, Vibrio parahaemolyticus is a leading cause of seafood-associated gastroenteritis. 
Historically, the V. parahaemolyticus serotypes O4:K12 and O4:KUT, which have been 
shown to be more virulent than other pathogenic V. parahaemolyticus strains, have been 
unique to the Pacific Northwest region.1 These strains, which were first identified in the 
Pacific Northwest in 1988, caused large U.S. outbreaks in 1997 and 2004.2 The outbreaks 
were linked to consumption of Pacific shellfish, but these strains have not been linked to 
illness or isolated outside the Pacific Northwest until recently.
During the summer of 2012, outbreaks of V. parahaemolyticus infection caused by these 
serotypes occurred on the Atlantic coasts of the United States and Spain. The U.S. Centers 
for Disease Control and Prevention received reports of 28 cases of infection from 9 states, 
and regional health authorities in Galicia in northwest Spain received reports of 51 cases, of 
which 9 were subsequently confirmed by laboratory tests.
The U.S. outbreak was linked to consumption of shellfish harvested from Oyster Bay 
Harbor, New York, between April and August 2012. The Spanish outbreak occurred in 
August 2012 on a cruise ship in Galicia and was epidemiologically linked to cooked seafood 
cooled with ice produced from untreated local seawater.
Disclosure forms provided by the authors are available with the full text of this letter at NEJM.org.
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Clinical isolates obtained from U.S. and Spanish patients were highly similar to Pacific 
Northwest strains on serologic tests, polymerase-chain-reaction assays for virulence factors, 
pulsed-field gel electrophoresis, and multilocus sequence typing (Table 1). The specificity of 
these subtyping methods used in combination indicates commonality among outbreak 
strains. The initial arrival and overall environmental distribution of, as well as the 
mechanism for the introduction of, the V. parahaemolyticus strains to the Atlantic coasts of 
the United States and Spain are unknown. However, importation and storage of live 
contaminated bivalve shellfish in local waters, ballast water movement,3 and long-distance 
oceanic transportation of strains into new regions4 are possible mechanisms. Both New York 
and Galicia have previously had outbreaks of V. parahaemolyticus infection caused by other 
strains, and both cities are near major ports. Both the U.S. and Spanish outbreaks 
corresponded temporally and spatially with higher-than-normal surface seawater 
temperatures, which have been associated with an increase in both the environmental 
prevalence of V. parahaemolyticus and illnesses.5
These strains were associated with illnesses on the U.S. Atlantic coast again this year; 
however, it is uncertain whether these strains will continue to persist or spread to other 
regions. Europe currently lacks systematic surveillance for noncholera vibrio species; this 
limits the identification of new strains and estimates of the burden of illness. We advocate 
continued and improved national and international collaboration and data sharing to help 
recognize and respond to future outbreaks of V. parahaemolyticus infection.
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Table 1
Vibrio parahaemolyticus Strains from Outbreaks in 2012 in the United States and Spain and Closely Matching 
Pacific Northwest Isolates.*
Strain
Year of Isolation
and Characterization Source Location Serotype
F11–3A 1988 Environmental Washington State O4:K12
48057 1990 Clinical Washington State O4:K12
10296 1997 Clinical Washington State O4:K12
029–1(b) 1997 Environmental Oregon O4:K12
10329 1998 Clinical Washington State O4:K12
CDC_2012V-1109 2012 Clinical Oyster Bay Harbor, New York O4:K12
CDC_2012V-1108 2012 Clinical Oyster Bay Harbor, New York O4:K12
CDC_M12–108 G 2012 Clinical Oyster Bay Harbor, New York O4:KUT
CDC_2012V-1131 2012 Clinical California O4:KUT
CDC_2012V-1132 2012 Clinical California O4:K12
CDC_2012V-1134 2012 Clinical Oyster Bay Harbor, New York O4:KUT
G35 2012 Clinical Spain O4:K12
G36 2012 Clinical Spain O4:K12
G37 2012 Clinical Spain O4:K12
*All isolates, which were positive for thermostable direct hemolysin and thermostable direct-related hemolysin, were multilocus sequence type 36.
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